Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Mimedx (MDXG) Other Working Capital Changes (2016 - 2026)

Mimedx's Other Working Capital Changes history spans 16 years, with the latest figure at $118000.0 for Q1 2026.

On a quarterly basis, Other Working Capital Changes fell 88.57% to $118000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$273000.0, a 171.28% decrease, with the full-year FY2025 number at $641000.0, up 82.1% from a year prior.
Other Working Capital Changes hit $118000.0 in Q1 2026 for Mimedx, up from $98000.0 in the prior quarter.
Over the last five years, Other Working Capital Changes for MDXG hit a ceiling of $1.3 million in Q2 2023 and a floor of -$1.3 million in Q4 2023.
Historically, Other Working Capital Changes has averaged $23588.2 across 5 years, with a median of $118000.0 in 2022.
The widest YoY moves for Other Working Capital Changes: up 1017.8% in 2023, down 618.43% in 2023.
Tracing MDXG's Other Working Capital Changes over 5 years: stood at $255000.0 in 2022, then plummeted by 618.43% to -$1.3 million in 2023, then surged by 50.91% to -$649000.0 in 2024, then soared by 115.1% to $98000.0 in 2025, then grew by 20.41% to $118000.0 in 2026.
Business Quant data shows Other Working Capital Changes for MDXG at $118000.0 in Q1 2026, $98000.0 in Q4 2025, and $698000.0 in Q3 2025.